Paul Uricchio

Paul Uricchio has extensive work experience in the pharmaceutical and medical device industry. Paul has worked in various roles, starting as a Pharmaceutical Sales Specialist at Pfizer in 1999. Paul then moved on to Novo Nordisk, where they worked as a Senior Diabetes Sales Specialist, responsible for launching and growing insulin formulations and delivery devices. During their time at Novo Nordisk, they also served as a Diabetes Marketing Intern, collaborating with a cross-functional team to develop and execute product brand plans.

Paul later joined sanofi-aventis as a Cardiovascular Specialist, contributing to the accelerated growth of LOVENOX and PLAVIX franchises. Paul consulted with institutional leadership and physicians to optimize thromboembolic disease management and drug utilization.

Following this, they worked at Johnson & Johnson in two different roles. As an Institutional Cardiovascular Specialist for Ortho-McNeil, they were responsible for sales and promotion of various products and played a key role in the launch of NUCYNTA. Later, as a Cardiovascular Specialist for Scios, they focused on stabilizing declining NATRECOR sales and providing consultation for inpatient Heart Failure disease management.

At Bristol-Myers Squibb, Paul served as a Surgical Sales Manager for ZymoGenetics, where they successfully increased profitability for Recothrom in a competitive market. Paul achieved the 2011 Circle of Excellence ranking, placing 5th nationally.

In their role as a Senior Product Manager at The Medicines Company, Paul led the go-to-market strategy for KENGREAL and ORBACTIV, launching both products in the hospital space. Paul also served as a Customer Solutions Manager, carrying the brands RECOTHROM and CLEVIPREX and consulting with key stakeholders in various medical specialties.

Paul then joined Mallinckrodt Pharmaceuticals as a Senior Product Manager, revitalizing a topical hemostatic agent franchise by launching new products and managing divestiture initiatives.

Their most recent role before the current one at Dilon Technologies Inc. was at Biom'up, where they held multiple roles. Paul led the global marketing and market expansion initiatives, including a successful launch in the Australian market. Paul later served as the Vice President of Global Marketing, Training, and Operations, overseeing global transformation and strategy execution.

Currently, Paul Uricchio holds the position of Global Marketing Director at Dilon Technologies Inc.

Paul Uricchio began their education in 1989 at Gannon University, where they pursued studies in an unspecified field. Paul completed their studies at Gannon University in 1991. Following this, they attended Lock Haven University of Pennsylvania from 1995 to 1997, earning a Bachelor of Arts degree in Speech Communications. Later, from 2009 to 2014, Paul Uricchio pursued a Master of Business Administration (MBA) degree in Healthcare & Pharmaceutical Marketing at Saint Joseph's University.